Diverticular Bleeding of the Colon during Combination Chemotherapy with Bevacizumab and Paclitaxel for Recurrent Breast Cancer

BACKGROUND: Bevacizumab has been increasingly used in combination chemotherapy with paclitaxel for treatment of metastatic or recurrent breast cancer. The aim of this report is to underline possible risks associated with the new combination chemotherapy. CASE PRESENTATION: A 39-year-old woman with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Yoshie, Ito, Yoshinori, Tanabe, Masahiko, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: January, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573816/
https://www.ncbi.nlm.nih.gov/pubmed/23467459
http://dx.doi.org/10.1159/000346839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573816/
https://www.ncbi.nlm.nih.gov/pubmed/23467459
http://dx.doi.org/10.1159/000346839

Ejemplares similares